Bausch Health Companies (BHC) Interest & Investment Income (2009 - 2026)

Bausch Health Companies has reported Interest & Investment Income for 18 years, with the latest figure at $11.0 million in Q2 2026.

• Quarterly Interest & Investment Income fell 15.38% year-over-year to $11.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $45.0 million (up 12.5% YoY) and the FY2025 annual result came in at $48.0 million, up 45.45% from the prior year.
• Interest & Investment Income improved to $11.0 million in Q2 2026 per BHC's latest filing, from $10.0 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $15.0 million in Q3 2025 and troughed at $2.0 million in Q1 2022.
• A 5-year average of $7.9 million and a median of $7.5 million in 2023 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2022 and 2026: Interest & Investment Income surged 500.0% in 2022, then dropped 15.38% in 2026.
• Over 5 years, Interest & Investment Income stood at $6.0 million in 2022, then rose by 16.67% to $7.0 million in 2023, then gained by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025, then climbed by 22.22% to $11.0 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $11.0 million, $10.0 million, and $9.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.